← Open Payments lookup

DIRK DEKERLEGAND: Open Payments

NPI 1679503965 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$384 in 21 payments from 9 companies in 2025. Trend: 2023 $705 · 2024 $40 · 2025 $384

Food & beverage: $384
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$98
Neurocrine BioSciences, Inc.4$86
E.R. Squibb & Sons, L.L.C.3$58
Vanda Pharmaceuticals Inc.2$39
Lundbeck LLC2$31
Janssen Pharmaceuticals, Inc1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
ABBVIE INC.1$17
Alkermes, Inc.1$14

Products named: INGREZZA, UZEDY, COBENFY, FANAPT, ABILIFY ASIMTUFII, INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA.

Industry payments across TX — which companies pay providers there.